Condition: Primary Open Angle Glaucoma (POAG) · Ocular Hypertension (OH) · Sponsor: YS Life Science Co., Ltd.
This study is to establish non-inferiority of a preservative free formulation of Bimatoprost ophthalmic solution 0.01% (YSBP) of YS Life Science Co., Ltd. compared to LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of AbbVie INC in subjects with primary open angle glaucoma (POAG) or ocular hypertension.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| National Clinical Trials | Beverly Hills, California, United States | Not Yet Recruiting |
| United medical research institute | Inglewood, California, United States | Not Yet Recruiting |
| Eye research foundation, Inc. | Newport Beach, California, United States | Recruiting |
| Visionary Eye Research Institute | Newport Beach, California, United States | Not Yet Recruiting |
| North Bay Eye Associates | Petaluma, California, United States | Not Yet Recruiting |
| Advanced research, LLC | Boynton Beach, Florida, United States | Not Yet Recruiting |
| Quantum clinical trials | Miami Beach, Florida, United States | Not Yet Recruiting |
| Advanced research, LLC | Weston, Florida, United States | Not Yet Recruiting |
| Clayton Eye Clinical Research | Morrow, Georgia, United States | Not Yet Recruiting |
| Coastal Research Associates, LLC | Roswell, Georgia, United States | Not Yet Recruiting |
| The eye care institute | Louisville, Kentucky, United States | Not Yet Recruiting |
| Tekwani vision center | St Louis, Missouri, United States | Not Yet Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07661329